• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分光光度法和电位滴定法测定药物制剂中的吡罗昔康和替诺昔康。

Spectrophotometric and potentiometric determination of piroxicam and tenoxicam in pharmaceutical preparations.

作者信息

El-Ries Mohamed A, Mohamed Gehad, Khalil Shaeban, El-Shall Manal

机构信息

National Organization for Drug Control and Research, Egypt.

出版信息

Chem Pharm Bull (Tokyo). 2003 Jan;51(1):6-10. doi: 10.1248/cpb.51.6.

DOI:10.1248/cpb.51.6
PMID:12520119
Abstract

Two simple and accurate methods are described for the determination of piroxicam and tenoxicam in their pharmaceutical preparations. The spectrophotometric method involves the oxidation of these drugs with potassium iodate in acid medium with the liberation of iodine and subsequent extraction with cyclohexane followed by measuring the absorbance at lambda=522 nm. Beer's law is obeyed in the concentration range of 0.05-1.1 and 0.05-0.6 mg x ml(-1) for piroxicam and tenoxicam, respectively. The apparent molar absorptivities of the resulting coloured products are found to be 2.7 x 10(3) and 2.5 x 10(3) l mol(-1) x cm(-1), whereas Sandell sensitivities are 0.012 and 0.013 g x cm(-2) for piroxicam and tenoxicam, respectively. The potentiometric method involves the direct titration of both drugs with N-bromosuccinimide in acid medium and the end point is determined potentiometrically using platinum indicator electrode. Piroxicam and tenoxicam can be determined quantitatively in the concentration range of 0.33-3.37 and 0.33-4.08 mg x ml(-1) for tenoxicam and piroxicam, respectively. The standard deviation and relative standard deviation values are found to be ranged from 0.05-0.07 and 0.37-0.98% and 0.025-0.078 and 0.25-1.2% for tenoxicam and piroxicam, respectively. The two methods are accurate within +/-1.0%. Optimum conditions affecting both methods are studied. The proposed methods are applied for the determination of the drugs in pure form and in commercial pharmaceutical preparations.

摘要

本文描述了两种简单且准确的方法,用于测定药物制剂中的吡罗昔康和替诺昔康。分光光度法是在酸性介质中用碘酸钾氧化这些药物,释放出碘,随后用环己烷萃取,然后在λ = 522 nm处测量吸光度。吡罗昔康和替诺昔康在浓度范围分别为0.05 - 1.1和0.05 - 0.6 mg·ml⁻¹时遵循比尔定律。所得有色产物的表观摩尔吸光系数分别为2.7×10³和2.5×10³ l·mol⁻¹·cm⁻¹,而桑德尔灵敏度对于吡罗昔康和替诺昔康分别为0.012和0.013 g·cm⁻²。电位滴定法是在酸性介质中用N - 溴代琥珀酰亚胺直接滴定这两种药物,使用铂指示电极通过电位法确定终点。替诺昔康和吡罗昔康分别在浓度范围为0.33 - 3.37和0.33 - 4.08 mg·ml⁻¹时可进行定量测定。替诺昔康和吡罗昔康的标准偏差和相对标准偏差值分别为0.05 - 0.07和0.37 - 0.98%以及0.025 - 0.078和0.25 - 1.2%。这两种方法的准确度在±1.0%以内。研究了影响这两种方法的最佳条件。所提出的方法应用于测定纯品形式和市售药物制剂中的药物。

相似文献

1
Spectrophotometric and potentiometric determination of piroxicam and tenoxicam in pharmaceutical preparations.分光光度法和电位滴定法测定药物制剂中的吡罗昔康和替诺昔康。
Chem Pharm Bull (Tokyo). 2003 Jan;51(1):6-10. doi: 10.1248/cpb.51.6.
2
Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical formulations using alizarin.使用茜素分光光度法测定药物制剂中的吡罗昔康和替诺昔康。
J Pharm Biomed Anal. 2002 Jul 20;29(4):729-36. doi: 10.1016/s0731-7085(02)00035-3.
3
Indirect flow-injection spectrophotometric determination of meloxicam, tenoxicam and piroxicam in pharmaceutical formulations.间接流动注射分光光度法测定药物制剂中的美洛昔康、替诺昔康和吡罗昔康。
Anal Sci. 2006 Dec;22(12):1611-4. doi: 10.2116/analsci.22.1611.
4
Flow-injection spectrophotometric methods for the determination of tenoxicam.流动注射分光光度法测定替诺昔康
J Pharm Biomed Anal. 1999 Dec;21(4):731-8. doi: 10.1016/s0731-7085(99)00202-2.
5
Indirect spectrophotometric determination of propranolol hydrochloride and piroxicam in pure and pharmaceutical formulations.间接分光光度法测定纯品及药物制剂中的盐酸普萘洛尔和吡罗昔康。
Anal Sci. 2002 Jun;18(6):671-4. doi: 10.2116/analsci.18.671.
6
Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations.用于测定纯品及药物制剂中阿莫西林、环丙沙星和吡罗昔康的灵敏分光光度法。
J Pharm Biomed Anal. 2002 Jul 31;29(5):859-64. doi: 10.1016/s0731-7085(02)00210-8.
7
Spectrophotometric determination of iodine species in table salt and pharmaceutical preparations.分光光度法测定食盐和药物制剂中的碘形态
Chem Pharm Bull (Tokyo). 2008 Jul;56(7):888-93. doi: 10.1248/cpb.56.888.
8
New potentiometric and spectrophotometric methods for the determination of dextromethorphan in pharmaceutical preparations.用于测定药物制剂中右美沙芬的新电位滴定法和分光光度法。
Anal Sci. 2014;30(3):419-25. doi: 10.2116/analsci.30.419.
9
Sensitive and selective spectrophotometric assay of piroxicam in pure form, capsule and human blood serum samples via ion-pair complex formation.通过离子对络合物形成对纯吡罗昔康、胶囊和人血清样品进行灵敏且选择性的分光光度测定。
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Sep 15;130:238-44. doi: 10.1016/j.saa.2014.03.074. Epub 2014 Apr 2.
10
Spectrophotometric study of the reaction mechanism between DDQ as pi-acceptor and potassium iodate and flucloxacillin and dicloxacillin drugs and their determination in pure and in dosage forms.以二氯二氰基苯醌(DDQ)作为π-受体与碘酸钾以及氟氯西林和双氯西林药物之间反应机理的分光光度研究及其在纯品和剂型中的测定。
Spectrochim Acta A Mol Biomol Spectrosc. 2006 Sep;65(1):11-9. doi: 10.1016/j.saa.2005.09.020. Epub 2006 Jul 28.

引用本文的文献

1
Molecular imprinted polymer-based metal complex potentiometric sensor doped with carbon nanotubes for sensitive determination of piroxicam in spiked human plasma.基于分子印迹聚合物的碳纳米管掺杂金属配合物电位传感器用于加标人血浆中吡罗昔康的灵敏测定。
RSC Adv. 2025 Jul 14;15(30):24739-24749. doi: 10.1039/d5ra03851k. eCollection 2025 Jul 10.
2
Eco-Friendly High-Performance Thin-Layer Chromatography Method for the Determination of Tenoxicam in Commercial Formulations.用于测定市售制剂中替诺昔康的环保型高效薄层色谱法
ACS Omega. 2023 Oct 12;8(42):39936-39944. doi: 10.1021/acsomega.3c07252. eCollection 2023 Oct 24.
3
Electroanalytical Determination of the Antiinflammatory Drug Tenoxicam in Pharmaceutical Dosage Forms.
药物剂型中抗炎药替诺昔康的电分析测定
Turk J Pharm Sci. 2019 Jun;16(2):184-190. doi: 10.4274/tjps.galenos.2018.60783. Epub 2019 Mar 27.
4
Analysis of piroxicam in pharmaceutical formulation and human urine by dispersive liquid-liquid microextraction combined with spectrophotometry.采用分散液液微萃取结合分光光度法分析药物制剂和人尿中的吡罗昔康。
Adv Pharm Bull. 2013;3(1):37-44. doi: 10.5681/apb.2013.007. Epub 2013 Feb 7.
5
Development and Validation of HPTLC Method for Estimation of Tenoxicam and its Formulations.用于测定替诺昔康及其制剂的高效薄层色谱法的开发与验证
Indian J Pharm Sci. 2012 Jan;74(1):36-40. doi: 10.4103/0250-474X.102541.